Geisinger Urology team to host virtual information event about enlarged prostates
The session will offer potential patients the chance to learn more about Aquablation and Rezum. Participants will also have the opportunity to ask questions.
Aquablation therapy, using the power of water jet ablation and robotic precision, can provide best-in-class and long-lasting symptom relief with low rates of irreversible complications, regardless of the shape or size of a man’s prostate.
Rezum delivers a targeted, controlled dose of stored thermal energy in water vapor directly to the prostate gland.
The exact cause of enlarged prostates is unknown, but hormonal changes in older men do play a role in the enlargement of the prostate glands blocking the urethra. Patients with enlarged prostates often have frequent urination, blood in the urine, urinary incontinence, and urinary retention.
Registration is open until Nov. 3. Visit geisinger.org/menshealth to secure your spot.
About Geisinger
Geisinger is among the nation’s leading providers of value-based care, serving 1.2 million people in urban and rural communities across Pennsylvania. Founded in 1915 by philanthropist Abigail Geisinger, the non-profit system generates $10 billion in annual revenues across 134 care sites - including 10 hospital campuses, and Geisinger Health Plan, with 600,000 members in commercial and government plans. The Geisinger College of Health Sciences educates more than 5,000 medical professionals annually and conducts more than 1,400 clinical research studies. With 26,000 employees, including 1,600 employed physicians, Geisinger is among Pennsylvania’s largest employers with an estimated economic impact of $14 billion to the state’s economy. On March 31, 2024, Geisinger became the first member of Risant Health, a new nonprofit charitable organization created to expand and accelerate value-based care across the country. Learn more at geisinger.org or connect with us on Facebook, Instagram, LinkedIn and X.
